logo
Share SHARE
FONT-SIZE Plus   Neg

Boeing CEO's Annual Compensation Rises 16.3 %

Boeing Co.(BA), in a proxy filing, reported that its Chairman, President and Chief Executive Officer James McNerney's compensation for 2011 increased 16% to $22.96 million from $19.74 million a year earlier.

McNerney's 2011 compensation included a base salary of $1.93 million, stock awards of $3.42 million, option awards of $3.42 million, non-Equity incentive plan compensation of $8.70 million and all other compensation totaling $0.93 million.

Boeing CEO's fiscal 2010 compensation comprised base salary of $1.93 million, stock awards of $3.30 million, option awards of $3.30 million, non-equity incentive plan compensation of $4.43 million and all other compensation of $0.79 million.

In 2011, McNerney's target annual incentive payout remained at 170% of base salary with a maximum potential payout of 230% of base salary. McNerney received an annual incentive payout of about $4.4 million for 2011. In addition, Mr. McNerney received a 2009-2011 performance award of $4.26 million or 68% of the target set at the beginning of the performance period in 2009. In 2011, the Compensation Committee increased McNerney's aggregate target awards under its long-term incentive program to 590.7% of base salary. McNerney's aggregate long-term incentive target awards were 650% of base salary in 2009 and 570% of base salary in 2010.

The airlines company reported that its Executive V.P., Corporate President and Chief Financial Officer James Bell's compensation also increased to $7.07 million from $5.39 million from last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT